MedPath

Study on the efficacy of LED phototherapy in patients with seasonal allergic rhinitis

Phase 3
Conditions
seasonal allergic rhinitis
Registration Number
JPRN-jRCTs032220525
Lead Sponsor
Tanigawa Takeshi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
22
Inclusion Criteria

1) Men and women between the ages of 18 and 50 years old at the time of informed consent
2) Patients diagnosed with allergic rhinitis
3) Patients with cedar-specific IgE antibodies
4) Patients who have start the treatment of allergic rhinitis
5) Patients who are able to visit Juntendo Hospital or Hongo Otorhinolaryngology Clinic
6) Patients who have given a full explanation of their participation in this study and who have given written consent of their own free will.

Exclusion Criteria

1) Patients undergoing treatment for or with a history of peripheral neuropathy or photosensitivity
2) Patients who are being treated for or have a history of mental illness, stroke, or myocardial infarction
3) Patients who are pregnant or planning to become pregnant during the study period
4) Patients who are using steroids (oral or injectable) or biological agents for the treatment of allergic rhinits
5) Patients who started taking allergic rhinitis medication or who have changed or added to their medication within 4 weeks prior to the start of the intervention.
6) Any other Patients who is deemed by the physician to be ineligible to participate in the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath